Innovative models for providing clinical pharmacy services to remote locations using clinical video telehealth

Perdew, Cassie; Erickson, Katie; Litke, Jessica

doi:10.2146/ajhp160625

Cited by 34 publications

(35 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It may be that certain demographics or other patient-specific attributes are better suited or prefer the alternative of pharmacist-led telehealth interventions to usual care. 10 This systematic review demonstrated that on the currently available RCT evidence, pharmacist-led telehealth provides an acceptable adjunct to usual care which may improve health outcomes or provide a potential alternative where usual care cannot be given. This research is topical as many service providers move rapidly to pharmacist-led telehealth in response to COVID-19.…”

Section: Discussionmentioning

confidence: 95%

“…To maintain access to pharmacist services to support medicines management, pharmacist-led telehealth has emerged as an important consideration. 10 Other research has investigated pharmacist involvement in multidisciplinary telehealth teams 3 or where the outcomes of interest were medication adherence. 11 Our interest was to investigate pharmacist-led telehealth on health outcomes compared to usual care or alternative care.…”

Section: Introductionmentioning

confidence: 99%

“…Reduced access to care has been demonstrated to adversely affect outcomes, making these alternative models appealing. To maintain access to pharmacist services to support medicines management, pharmacist‐led telehealth has emerged as an important consideration 10 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Lowry

Kay

Marsom

et al. 2020

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background: Pharmacist-led telehealth is an innovative service delivery model that may provide an alternative mode of care. It remains unclear how surrogate markers of health conditions differ when pharmacist services are delivered via telehealth compared to usual care. Aims: To assess if pharmacist-led telehealth interventions alter surrogate markers of health conditions. Methods: Pharmacist-led telehealth interventions compared to another active intervention for people using one or more regular medicines were included that reported surrogate markers of health conditions. Scopus, Embase, Medline and CINAHL were searched from inception to May 2020 to identify randomised controlled trials. Researchers screened articles to identify eligible studies, then data were extracted using a standardised data collection sheet. Quality assessment was undertaken using the Cochrane risk of bias tool. Data were reported as risk ratio and mean difference with corresponding 95% confidence intervals. Results: Of 1896 titles identified, 11 studies met the inclusion criteria. Telehealth interventions by pharmacists consisted of multifaceted interventions with contact over differing time durations. Some blood pressure and oral anticoagulation clinical outcomes were improved in the pharmacist-led telehealth group compared to the control group. However, the majority of outcomes were similar in both groups. Conclusion: This study identified that pharmacist-led telehealth interventions for a select range of chronic health conditions provides an acceptable adjunct to usual care and results in similar health outcomes for surrogate markers when compared to usual care.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Lowry

Kay

Marsom

et al. 2020

Pharmacy Practice and Res

View full text Add to dashboard Cite

show abstract

“…There appears to be clear benefit in improving safety and mitigating medication errors in the outpatient care arena. [1][2][3][4][5][6][7][8][9] Some articles discuss tele-emergency pharmacy care for inpatients within intensive care and behavioural health units, 10 but our literature search provided no documented cases of a clinical pharmacist working in teleemergency medicine providing real-time, synchronous care to a remote, rural ED.…”

Section: Discussionmentioning

confidence: 99%

Ethylene glycol and methanol ingestion cared for by tele-emergency pharmacy and tele-emergency medicine

et al. 2018

View full text Add to dashboard Cite

show abstract

“…9 Kaiser Permanente of Northern California discovered that while promoting the use of telehealth services increased the number of healthcare visits by roughly six million over the course of five years, the overall goal of the telehealth structural model should be to reduce healthcare expenditures in the long-term. 10 Another one of the biggest advocates for the use of telemedicine is the Veterans Health Administration 11 , with their national telehealth programs having served over 600,000 veterans, corresponding to more than two million telehealth visits performed in 2014. 12…”

Section: Introductionmentioning

confidence: 99%

Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review

Littauer¹,

Dixon²,

Mishra³

et al. 2017

Pharm Pract (Granada)

View full text Add to dashboard Cite

Telemedicine refers to the delivery of clinical services using technology that allows two-way, real time, interactive communication between the patient and the clinician at a distant site. Commonly, telemedicine is used to improve access to general and specialty care for patients in rural areas. This review aims to provide an overview of existing telemedicine models involving the delivery of care by pharmacists via telemedicine (including telemonitoring and video, but excluding follow-up telephone calls) and to highlight the main areas of chronic-disease management where these models have been applied. Studies within the areas of hypertension, diabetes, asthma, anticoagulation and depression were identified, but only two randomized controlled trials with adequate sample size demonstrating the positive impact of telemonitoring combined with pharmacist care in hypertension were identified. The evidence for the impact of pharmacist-based telemedicine models is sparse and weak, with the studies conducted presenting serious threats to internal and external validity. Therefore, no definitive conclusions about the impact of pharmacist-led telemedicine models can be made at this time. In the Unites States, the increasing shortage of primary care providers and specialists represents an opportunity for pharmacists to assume a more prominent role managing patients with chronic disease in the ambulatory care setting. However, lack of reimbursement may pose a barrier to the provision of care by pharmacists using telemedicine.

show abstract

Innovative models for providing clinical pharmacy services to remote locations using clinical video telehealth

Abstract: Within the VA healthcare system, telehealth technology has been demonstrated to be a cost-effective and well-received means of providing clinical pharmacy services in rural areas.

Cited by 34 publications

References 6 publications

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Ethylene glycol and methanol ingestion cared for by tele-emergency pharmacy and tele-emergency medicine

Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review

Contact Info

Product

Resources

About